Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced a final cash dividend of RMB 0.4 per share for the financial year ending December 31, 2024. The dividend will be paid in Hong Kong dollars at a rate of HKD 0.4362 per share, with a payment date set for July 18, 2025. The announcement includes details on withholding tax rates applicable to different categories of shareholders, impacting both resident and non-resident stakeholders. This move reflects the company’s financial health and commitment to returning value to its shareholders.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$25.40 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is known for its range of traditional Chinese medicines and modern pharmaceuticals, catering to both domestic and international markets.
Average Trading Volume: 1,388,448
Technical Sentiment Signal: Sell
Current Market Cap: HK$45.22B
For a thorough assessment of 0874 stock, go to TipRanks’ Stock Analysis page.